University of Texas/Texas AM Investment Management Co (UTIMCO) Portfolio holdings
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Spyre Therapeutics
SYRE
|
+$2.92M |
| 2 |
Rockwell Automation
ROK
|
+$1.98M |
| 3 |
Vanguard FTSE Developed Markets ETF
VEA
|
+$930K |
| 4 |
RETA
Reata Pharmaceuticals, Inc. Class A Common Stock
RETA
|
+$544K |
| 5 |
Vanguard Morningstar Mid-Cap Value ETF
VOE
|
+$451K |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Agios Pharmaceuticals
AGIO
|
+$1.68M |
| 2 |
Vanguard Energy ETF
VDE
|
+$1.15M |
| 3 |
Vanguard Real Estate ETF
VNQ
|
+$650K |
| 4 |
Intel
INTC
|
+$161K |
| 5 |
Berkshire Hathaway Class B
BRK.B
|
+$159K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 26.89% |
| 2 | Energy | 17.27% |
| 3 | Technology | 6.02% |
| 4 | Industrials | 5.52% |
| 5 | Materials | 2.34% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
26
Agios Pharmaceuticals
AGIO
$2.04B
| – | – |
-40,000
| Closed | -$1.68M |
|
|
27
Berkshire Hathaway Class B
BRK.B
$1.09T
| – | – |
-1,097
| Closed | -$159K |
|
28
Hewlett Packard
HPE
$81.9B
| – | – |
-1,721
| Closed | -$18K |
|
|
29
Intel
INTC
$515B
| – | – |
-4,919
| Closed | -$161K |
|
30
Johnson & Johnson
JNJ
$629B
| – | – |
-113
| Closed | -$14K |
|
|
CXO
31
DELISTED
CONCHO RESOURCES INC.
CXO
| – | – |
-925
| Closed | -$110K |
|
|
WFM
32
DELISTED
Whole Foods Market Inc
WFM
| – | – |
-1,000
| Closed | -$32K |
|
Similar funds
University of Texas/Texas AM Investment Management Co (UTIMCO)'s Q3 2016 Portfolio in Review
As of Q3 2016, University of Texas/Texas AM Investment Management Co (UTIMCO) held 32 positions worth $37.5M, up 9% from $34.4M the previous quarter. Its ten largest holdings account for 91% of the portfolio.
University of Texas/Texas AM Investment Management Co (UTIMCO) deployed $3.37M of net new capital in Q3 2016, opening 10 new positions and adding to 4 existing holdings. Its largest new stake was Spyre Therapeutics: 20,997 shares worth $3.37M.
By sector, the portfolio is most concentrated in Healthcare at 27% of assets, down from 28% a quarter earlier, followed by Energy and Technology.
On the sell side, the largest reduction was Vanguard Energy ETF, an estimated $1.15M trimmed.
- University of Texas/Texas AM Investment Management Co (UTIMCO)'s largest Q3 2016 buy was Spyre Therapeutics: 20,997 shares worth $3.37M.
- University of Texas/Texas AM Investment Management Co (UTIMCO) added most to Vanguard FTSE Developed Markets ETF in Q3 2016, an estimated $930K increase.
- University of Texas/Texas AM Investment Management Co (UTIMCO)'s biggest Q3 2016 reduction was Vanguard Energy ETF, cutting an estimated $1.15M.
- University of Texas/Texas AM Investment Management Co (UTIMCO) fully exited Agios Pharmaceuticals in Q3 2016, selling an estimated $1.68M.
- University of Texas/Texas AM Investment Management Co (UTIMCO)'s ten largest holdings make up 91% of its $37.5M portfolio in Q3 2016.
- University of Texas/Texas AM Investment Management Co (UTIMCO) opened 10 new positions and closed 7 in Q3 2016.
- University of Texas/Texas AM Investment Management Co (UTIMCO)'s portfolio value rose 9% quarter-over-quarter to $37.5M.
Based on University of Texas/Texas AM Investment Management Co (UTIMCO)'s 13F filing for Q3 2016, filed 3 Nov 2016.